Application 071295
- Type
- ANDA
- Sponsor
- ABBVIE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATROPINE | ATROPINE | SOLUTION;INTRAMUSCULAR | EQ 2MG SULFATE/0.7ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A071295-001 | ATROPINE | ATROPINE | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | 1987-01-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A071295-001 | ATROPINE | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | 1987-01-30 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A071295-001 | ATROPINE | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | 1987-01-30 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A071295-001 | ATROPINE | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | 1987-01-30 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A071295-001 | ATROPINE | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | 1987-01-30 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atropine | ATROPINE SULFATE | Gland Pharma Limited | a116af5c-ba4c-408c-9a02-4bc33772aa8d | 2026-08-03 | Warnings, Adverse reactions | Atropine |
| Atropine | ATROPINE SULFATE | Apotex Corp. | 127a7e32-a150-01d6-a66a-b7708d85809f | 2026-03-10 | Warnings, Adverse reactions | Atropine |
| ATROPINE | ATROPINE SULFATE | A-S Medication Solutions | b4736dbc-b7c8-4b33-b7a8-a47c5654a127 | 2026-02-10 | Warnings, Adverse reactions | ATROPINE |
| Atropine | ATROPINE SULFATE | Redpharm Drug | 46e98d0b-3a04-7feb-e063-6394a90ac75e | 2025-12-27 | Warnings, Adverse reactions | Atropine |
| Atropine | ATROPINE SULFATE | Amneal Pharmaceuticals NY LLC | f8718be5-8fa4-4c36-a4fd-fac7c3953f5a | 2025-12-04 | Warnings, Adverse reactions | Atropine |
| Atropine | ATROPINE SULFATE | A-S Medication Solutions | 1b2d030e-c0ec-484b-a228-76011702cdd0 | 2024-01-02 | Warnings, Adverse reactions | Atropine |
| ATROPEN Auto-Injector | ATROPINE | Meridian Medical Technologies LLC | e2d4307d-da8f-49f5-aac0-02355dd9ffb7 | 2022-09-15 | Warnings, Adverse reactions | ATROPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.